| Stephanie Ann Ware, CRNA | |
|
475 Seaview Ave, Staten Island, NY 10305-3436 | |
| (718) 226-2000 | |
| Not Available |
| Full Name | Stephanie Ann Ware |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 475 Seaview Ave, Staten Island, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255339149 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 26NJ00216900 (New Jersey) | Primary |
| Entity Name | Jersey Shore Anesthesiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538190764 PECOS PAC ID: 9830003052 Enrollment ID: O20031113000003 |
News Archive
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A new, international study from the Chronic Kidney Disease Prognosis Consortium found that use of blood levels of cystatin C to estimate kidney function—alone or in combination with creatinine—strengthens the association between kidney function and risks of death and end-stage renal disease.
AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published in the Journal of Biological Chemistry.
In testimony before the House Committee on Veterans' Affairs, Acting Inspector General Richard Griffin says that delays in getting treatment at some VA centers may have been a factor in the deaths of some veterans.
› Verified 4 days ago
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A new, international study from the Chronic Kidney Disease Prognosis Consortium found that use of blood levels of cystatin C to estimate kidney function—alone or in combination with creatinine—strengthens the association between kidney function and risks of death and end-stage renal disease.
AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published in the Journal of Biological Chemistry.
In testimony before the House Committee on Veterans' Affairs, Acting Inspector General Richard Griffin says that delays in getting treatment at some VA centers may have been a factor in the deaths of some veterans.
› Verified 4 days ago
| Entity Name | Anesthesia Associates Of Morristown Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922057678 PECOS PAC ID: 7315906591 Enrollment ID: O20041004000993 |
News Archive
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A new, international study from the Chronic Kidney Disease Prognosis Consortium found that use of blood levels of cystatin C to estimate kidney function—alone or in combination with creatinine—strengthens the association between kidney function and risks of death and end-stage renal disease.
AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published in the Journal of Biological Chemistry.
In testimony before the House Committee on Veterans' Affairs, Acting Inspector General Richard Griffin says that delays in getting treatment at some VA centers may have been a factor in the deaths of some veterans.
› Verified 4 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A new, international study from the Chronic Kidney Disease Prognosis Consortium found that use of blood levels of cystatin C to estimate kidney function—alone or in combination with creatinine—strengthens the association between kidney function and risks of death and end-stage renal disease.
AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published in the Journal of Biological Chemistry.
In testimony before the House Committee on Veterans' Affairs, Acting Inspector General Richard Griffin says that delays in getting treatment at some VA centers may have been a factor in the deaths of some veterans.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Ann Ware, CRNA Po Box 10049, New York, NY 10259-0049 Ph: (201) 804-2800 | Stephanie Ann Ware, CRNA 475 Seaview Ave, Staten Island, NY 10305-3436 Ph: (718) 226-2000 |
News Archive
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A new, international study from the Chronic Kidney Disease Prognosis Consortium found that use of blood levels of cystatin C to estimate kidney function—alone or in combination with creatinine—strengthens the association between kidney function and risks of death and end-stage renal disease.
AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published in the Journal of Biological Chemistry.
In testimony before the House Committee on Veterans' Affairs, Acting Inspector General Richard Griffin says that delays in getting treatment at some VA centers may have been a factor in the deaths of some veterans.
› Verified 4 days ago
Mr. Ishu Kumar, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 411 Holdridge Ave, Staten Island, NY 10312 Phone: 646-358-2549 | |
Edjona Groysman, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 130 Stroud Ave, Staten Island, NY 10312 Phone: 347-215-2015 | |
Lisa Jean Pierre, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-9000 | |
Tomcy Varghese, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 355 Bard Ave, Staten Island, NY 10310 Phone: 718-818-1234 | |
Shehzad Ahmed, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 355 Bard Ave, Staten Island, NY 10310 Phone: 718-818-1234 | |
Joseph V Caputo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-2000 |